These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
OR
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Maryland
|
|
38-3888962
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
405 Park Ave., 15
th
Floor, New York, NY
|
|
10022
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
(212) 415-6500
|
||
|
(Registrant's telephone number, including area code)
|
||
|
Large accelerated filer
o
|
|
Accelerated filer
o
|
|
Non-accelerated filer
x
|
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
2013 |
|
December 31,
2012 |
||||
|
|
(Unaudited)
|
|
|
||||
|
ASSETS
|
|
|
|
||||
|
Real estate investments, at cost:
|
|
|
|
||||
|
Land
|
$
|
409
|
|
|
$
|
—
|
|
|
Buildings, fixtures and improvements
|
6,047
|
|
|
—
|
|
||
|
Acquired intangible lease assets
|
910
|
|
|
—
|
|
||
|
Total real estate investments, at cost
|
7,366
|
|
|
—
|
|
||
|
Less accumulated depreciation and amortization
|
(16
|
)
|
|
—
|
|
||
|
Total real estate investments, net
|
7,350
|
|
|
—
|
|
||
|
Cash
|
17,050
|
|
|
3
|
|
||
|
Receivable for sale of common stock
|
1,558
|
|
|
—
|
|
||
|
Prepaid expenses and other assets
|
40
|
|
|
—
|
|
||
|
Deferred costs
|
—
|
|
|
807
|
|
||
|
Total assets
|
$
|
25,998
|
|
|
$
|
810
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
||||
|
Accounts payable and accrued expenses
|
$
|
1,208
|
|
|
$
|
625
|
|
|
Deferred rent and other liabilities
|
48
|
|
|
—
|
|
||
|
Distributions payable
|
118
|
|
|
—
|
|
||
|
Total liabilities
|
1,374
|
|
|
625
|
|
||
|
|
|
|
|
||||
|
Preferred stock, $0.01 par value, 50,000,000 authorized, none issued and outstanding at June 30, 2013 and December 31, 2012
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par value, 300,000,000 shares authorized, 1,216,746 and 8,888 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively
|
12
|
|
|
—
|
|
||
|
Additional paid-in capital
|
24,924
|
|
|
200
|
|
||
|
Accumulated deficit
|
(312
|
)
|
|
(15
|
)
|
||
|
Total stockholders' equity
|
24,624
|
|
|
185
|
|
||
|
Total liabilities and stockholders' equity
|
$
|
25,998
|
|
|
$
|
810
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||
|
|
|
June 30, 2013
|
|
June 30, 2013
|
||||
|
|
|
|
|
|
||||
|
Revenues:
|
|
|
|
|
||||
|
Rental income
|
|
$
|
26
|
|
|
$
|
26
|
|
|
Operating expense reimbursement
|
|
1
|
|
|
1
|
|
||
|
Total revenues
|
|
27
|
|
|
27
|
|
||
|
|
|
|
|
|
||||
|
Expenses:
|
|
|
|
|
||||
|
Property operating
|
|
1
|
|
|
1
|
|
||
|
Acquisition and transaction related
|
|
118
|
|
|
118
|
|
||
|
General and administrative
|
|
8
|
|
|
55
|
|
||
|
Depreciation and amortization
|
|
16
|
|
|
16
|
|
||
|
Total expenses
|
|
143
|
|
|
190
|
|
||
|
Net loss
|
|
$
|
(116
|
)
|
|
$
|
(163
|
)
|
|
Comprehensive loss
|
|
$
|
(116
|
)
|
|
$
|
(163
|
)
|
|
|
|
|
|
|
||||
|
Basic and diluted weighted average shares outstanding
|
|
379,911
|
|
|
195,425
|
|
||
|
Basic and diluted net loss per share
|
|
$
|
(0.31
|
)
|
|
$
|
(0.83
|
)
|
|
|
Common Stock
|
|
|
|
|
|
|
|||||||||||
|
|
Number of
Shares
|
|
Par Value
|
|
Additional
Paid-in
Capital
|
|
Accumulated Deficit
|
|
Total Stockholders' Equity
|
|||||||||
|
Balance, December 31, 2012
|
8,888
|
|
|
$
|
—
|
|
|
$
|
200
|
|
|
$
|
(15
|
)
|
|
$
|
185
|
|
|
Issuance of common stock
|
1,203,487
|
|
|
12
|
|
|
29,728
|
|
|
—
|
|
|
29,740
|
|
||||
|
Common stock offering costs, commissions and dealer manager fees
|
—
|
|
|
—
|
|
|
(5,020
|
)
|
|
—
|
|
|
(5,020
|
)
|
||||
|
Common stock issued through distribution reinvestment plan
|
372
|
|
|
—
|
|
|
9
|
|
|
—
|
|
|
9
|
|
||||
|
Share-based compensation
|
3,999
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
7
|
|
||||
|
Distributions declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(134
|
)
|
|
(134
|
)
|
||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(163
|
)
|
|
(163
|
)
|
||||
|
Balance, June 30, 2013
|
1,216,746
|
|
|
$
|
12
|
|
|
$
|
24,924
|
|
|
$
|
(312
|
)
|
|
$
|
24,624
|
|
|
|
Six Months Ended
|
||
|
|
June 30, 2013
|
||
|
Cash flows from operating activities:
|
|
||
|
Net loss
|
$
|
(163
|
)
|
|
Adjustment to reconcile net loss to net cash used in operating activities:
|
|
||
|
Depreciation
|
13
|
|
|
|
Amortization of intangibles
|
3
|
|
|
|
Share-based compensation
|
7
|
|
|
|
Changes in assets and liabilities:
|
|
||
|
Prepaid expenses and other assets
|
(40
|
)
|
|
|
Accounts payable and accrued expenses
|
100
|
|
|
|
Deferred rent and other liabilities
|
48
|
|
|
|
Net cash used in operating activities
|
(32
|
)
|
|
|
Cash flows from investing activities:
|
|
||
|
Investment in real estate and other assets
|
(7,366
|
)
|
|
|
Net cash used in investing activities
|
(7,366
|
)
|
|
|
Cash flows from financing activities:
|
|
||
|
Proceeds from issuance of common stock
|
28,182
|
|
|
|
Payments of offering costs and fees related to common stock issuances
|
(3,633
|
)
|
|
|
Distributions paid
|
(7
|
)
|
|
|
Advances from affiliate, net
|
(97
|
)
|
|
|
Net cash provided by financing activities
|
24,445
|
|
|
|
Net change in cash
|
17,047
|
|
|
|
Cash, beginning of period
|
3
|
|
|
|
Cash, end of period
|
$
|
17,050
|
|
|
|
|
||
|
Supplemental Disclosures:
|
|
||
|
Cash paid for taxes
|
$
|
1
|
|
|
|
|
||
|
Non-Cash Financing Activities:
|
|
||
|
Common stock issued through distribution reinvestment plan
|
$
|
9
|
|
|
Reclassification of deferred offering costs to equity
|
807
|
|
|
|
|
|
Six Months Ended
|
||
|
(Dollar amounts in thousands)
|
|
June 30, 2013
|
||
|
Real estate investments, at cost:
|
|
|
||
|
Land
|
|
$
|
409
|
|
|
Buildings, fixtures and improvements
|
|
6,047
|
|
|
|
Total tangible assets
|
|
6,456
|
|
|
|
Acquired intangibles:
|
|
|
||
|
In-place leases
|
|
910
|
|
|
|
Total assets acquired, net
|
|
7,366
|
|
|
|
Cash paid for acquired real estate investments
|
|
$
|
7,366
|
|
|
Number of properties purchased
|
|
2
|
|
|
|
|
|
Six Months Ended
|
||
|
(In thousands)
|
|
June 30, 2013
|
||
|
Pro forma revenues
|
|
$
|
313
|
|
|
Pro forma net income
|
|
$
|
44
|
|
|
(In thousands)
|
|
Future Minimum
Base Rent Payments
|
||
|
July 1, 2013 — December 31, 2013
|
|
$
|
286
|
|
|
2014
|
|
572
|
|
|
|
2015
|
|
572
|
|
|
|
2016
|
|
572
|
|
|
|
2017
|
|
585
|
|
|
|
Thereafter
|
|
3,385
|
|
|
|
|
|
$
|
5,972
|
|
|
|
|
June 30,
|
|
Tenant
|
|
2013
|
|
Adena Health System
|
|
72.6%
|
|
Fresenius Medical Care AG & Co. KGaA
|
|
27.4%
|
|
|
|
June 30,
|
|
|
State
|
|
2013
|
|
|
Alabama
|
|
27.4
|
%
|
|
Ohio
|
|
72.6
|
%
|
|
|
|
Three and Six Months Ended
|
|
Payable as of
|
||||||||
|
(In thousands)
|
|
June 30, 2013
|
|
June 30, 2013
|
|
December 31,
|
||||||
|
Total commissions and fees incurred from the Dealer Manager
|
|
$
|
2,745
|
|
|
$
|
138
|
|
|
$
|
—
|
|
|
|
|
Three and Six Months Ended
|
|
Payable as of
|
||||||||
|
(In thousands)
|
|
June 30, 2013
|
|
June 30, 2013
|
|
December 31,
|
||||||
|
Fees and expense reimbursements from the Advisor and Dealer Manager
|
|
$
|
715
|
|
|
$
|
444
|
|
|
$
|
—
|
|
|
|
|
Three and Six Months Ended
|
|
Payable as of
|
||||||||||||
|
|
|
June 30, 2013
|
|
June 30,
|
|
December 31,
|
||||||||||
|
(In thousands)
|
|
Incurred
|
|
Forgiven
|
|
2013
|
|
2012
|
||||||||
|
One-time fees and reimbursements:
|
|
|
|
|
|
|
|
|
||||||||
|
Acquisition fees and related cost reimbursements
|
|
$
|
84
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Financing coordination fees
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Other expense reimbursements
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Ongoing fees:
|
|
|
|
|
|
|
|
|
||||||||
|
Property management and leasing fees
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Strategic advisory fees
|
|
28
|
|
|
—
|
|
|
28
|
|
|
—
|
|
||||
|
Total related party operation fees and reimbursements
|
|
$
|
112
|
|
|
$
|
—
|
|
|
$
|
28
|
|
|
$
|
—
|
|
|
|
|
Three and Six
Months Ended
|
||
|
(In thousands)
|
|
June 30, 2013
|
||
|
Property operating expenses absorbed
|
|
$
|
—
|
|
|
General and administrative expenses absorbed
|
|
177
|
|
|
|
Total expenses absorbed
(1)
|
|
$
|
177
|
|
|
|
|
Three Months Ended June 30, 2013
|
|
Six Months Ended June 30, 2013
|
||||
|
Net loss
(in thousands)
|
|
$
|
(116
|
)
|
|
$
|
(163
|
)
|
|
Basic and diluted weighted average shares outstanding
|
|
379,911
|
|
|
195,425
|
|
||
|
Basic and diluted net loss per share
|
|
$
|
(0.31
|
)
|
|
$
|
(0.83
|
)
|
|
|
|
June 30, 2013
|
|
|
Unvested restricted stock
|
|
3,999
|
|
|
Source of Capital
(in thousands)
|
|
Inception to June 30, 2013
|
|
July 1, 2013 to July 31, 2013
|
|
Total
|
||||||
|
Common stock
|
|
$
|
29,949
|
|
|
$
|
24,489
|
|
|
$
|
54,438
|
|
|
|
|
Number of Properties
|
|
Rentable
Square Feet
|
|
Base
Purchase Price
(1)
|
||||
|
|
|
|
|
|
|
(In thousands)
|
||||
|
Total portfolio, June 30, 2013
|
|
2
|
|
|
30,488
|
|
|
$
|
7,366
|
|
|
Acquisitions
|
|
2
|
|
|
45,460
|
|
|
18,109
|
|
|
|
Total portfolio, August 12, 2013
|
|
4
|
|
|
75,948
|
|
|
$
|
25,475
|
|
|
•
|
We have a limited operating history and the Advisor has limited experience operating a public company. This inexperience makes our future performance difficult to predict.
|
|
•
|
All of our executive officers are also officers, managers and/or holders of a direct or indirect controlling interest in our Advisor, our dealer manager, Realty Capital Securities, LLC (the "Dealer Manager") and other American Realty Capital affiliated entities. As a result, our executive officers, our Advisor and its affiliates face conflicts of interest, including significant conflicts created by our Advisor's compensation arrangements with us and other investment programs advised by American Realty Capital affiliates and conflicts in allocating time among these investment programs and us. These conflicts could result in unanticipated actions.
|
|
•
|
Because investment opportunities that are suitable for us may also be suitable for other American Realty Capital advised investment programs, our Advisor and its affiliates face conflicts of interest relating to the purchase of properties and other investments and such conflicts may not be resolved in our favor, meaning that we could invest in less attractive assets, which could reduce the investment return to our stockholders.
|
|
•
|
Within six months following our acquisition of $2.0 billion in total portfolio assets, the purchase price and repurchase price for our shares will be based on our net asset value ("NAV") rather than a public trading market. Our published NAV may not accurately reflect the value of our assets. No public market currently exists, or may ever exist, for our shares of our common stock and our shares are, and may continue to be, illiquid.
|
|
•
|
We focus on acquiring a diversified portfolio of healthcare-related assets located in the United States and are subject to risks inherent in concentrating investments in the healthcare industry.
|
|
•
|
The healthcare industry is heavily regulated, and new laws or regulations, changes to existing laws or regulations, loss of licensure or failure to obtain licensure could result in the inability of tenants to make lease payments to us.
|
|
•
|
If we and our Advisor are unable to find suitable investments, then we may not be able to achieve our investment objectives or pay distributions.
|
|
•
|
Our initial public offering of common stock (the "IPO"), which commenced on February 14, 2013, is a blind pool offering and you may not have the opportunity to evaluate our investments before you make your purchase of our common stock, thus making your investment more speculative.
|
|
•
|
If we raise substantially less than the maximum offering in our IPO, we may not be able to invest in a diversified portfolio of real estate assets and the value of an investment in us may vary more widely with the performance of specific assets.
|
|
•
|
We may be unable to pay or maintain cash distributions or increase distributions over time.
|
|
•
|
We are obligated to pay substantial fees to our Advisor and its affiliates.
|
|
•
|
We will depend on tenants for our revenue and, accordingly, our revenue is dependent upon the success and economic viability of our tenants.
|
|
•
|
Increases in interest rates could increase the amount of our debt payments and limit our ability to pay distributions.
|
|
•
|
Organizational documents permit us to pay distributions from unlimited amounts of any source. Until substantially all of the proceeds from our IPO are invested, we may use proceeds from our IPO and financings to fund distributions until we have sufficient cash flow. There are not established limits on the amount of net proceeds and borrowings that we may use to fund distribution payments.
|
|
•
|
Any distributions may reduce the amount of capital we ultimately invest in properties and other permitted investments and negatively impact the value of your investment.
|
|
•
|
We may not generate cash flows sufficient to pay our distributions to stockholders, as such, we may be forced to borrow at higher rates or depend on our Advisor to waive reimbursement of certain expenses and fees to fund our operations.
|
|
•
|
We are subject to risks associated with any dislocations or liquidity disruptions that may exist or occur in the credit markets of the United States of America from time to time.
|
|
•
|
We may fail to qualify, or continue to qualify, to be treated as a real estate investment trust ("REIT") for U.S. federal income tax purposes, which would result in higher taxes, may adversely affect our operations and would reduce our NAV and cash available for distributions.
|
|
•
|
We may be deemed to be an investment company under the Investment Company Act of 1940, as amended (the "Investment Company Act"), and thus subject to regulation under the Investment Company Act of 1940, as amended.
|
|
•
|
As of
June 30, 2013
, we only own
two
properties and therefore, have limited diversification.
|
|
•
|
a significant decrease in the market price of a long-lived asset;
|
|
•
|
a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition;
|
|
•
|
a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, including an adverse action or assessment by a regulator;
|
|
•
|
an accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset; and
|
|
•
|
a current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset.
|
|
Portfolio
|
|
Acquisition
Date
|
|
Number
of Properties
|
|
Rentable
Square Feet
|
|
Occupancy
|
|
Remaining
Lease Term
(1)
|
|
Base Purchase Price
(2)
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands)
|
|||
|
Fresenius Dialysis Center
|
|
May 2013
|
|
1
|
|
5,564
|
|
|
100.0%
|
|
9.7
|
|
$
|
1,920
|
|
|
Adena Health Center
|
|
Jun. 2013
|
|
1
|
|
24,924
|
|
|
100.0%
|
|
10.7
|
|
5,446
|
|
|
|
|
|
|
|
2
|
|
30,488
|
|
|
100.0%
|
|
10.4
|
|
$
|
7,366
|
|
|
(1)
|
Remaining lease term in years as of
June 30, 2013
, calculated on a weighted-average basis, as applicable.
|
|
(2)
|
Contract purchase price, excluding acquisition related costs.
|
|
|
|
Three Months Ended
|
||
|
(In thousands)
|
|
June 30, 2013
|
||
|
Net loss (in accordance with GAAP)
|
|
$
|
(116
|
)
|
|
Depreciation and amortization
|
|
16
|
|
|
|
FFO
|
|
(100
|
)
|
|
|
Acquisition fees and expenses
(1)
|
|
118
|
|
|
|
Straight-line rent
(2)
|
|
(1
|
)
|
|
|
MFFO
|
|
$
|
17
|
|
|
|
|
Three Months Ended
|
|||||
|
|
|
June 30, 2013
|
|||||
|
(In thousands)
|
|
|
|
Percentage of Distributions
|
|||
|
Distributions:
|
|
|
|
|
|||
|
Distributions paid in cash
|
|
$
|
7
|
|
|
|
|
|
Distributions reinvested
|
|
9
|
|
|
|
||
|
Total distributions
|
|
$
|
16
|
|
|
|
|
|
|
|
|
|
|
|||
|
Source of distribution coverage:
|
|
|
|
|
|||
|
Cash flows provided by operations
(1)
|
|
$
|
—
|
|
|
—
|
%
|
|
Proceeds from issuance of common stock
|
|
7
|
|
|
43.7
|
%
|
|
|
Common stock issued under the DRIP / offering proceeds
|
|
9
|
|
|
56.3
|
%
|
|
|
Proceeds from financings
|
|
—
|
|
|
—
|
%
|
|
|
Total source of distribution coverage
|
|
$
|
16
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|||
|
Cash flows used in operations (GAAP basis)
(1)
|
|
$
|
(32
|
)
|
|
|
|
|
Net loss (in accordance with GAAP)
|
|
$
|
(116
|
)
|
|
|
|
|
|
|
For the Period
from October 15, 2012 (date of inception) to |
||
|
(In thousands)
|
|
June 30, 2013
|
||
|
Distributions paid:
|
|
|
||
|
Common stockholders in cash
|
|
$
|
7
|
|
|
Common stockholders pursuant to DRIP/offering proceeds
|
|
9
|
|
|
|
Total distributions paid
|
|
$
|
16
|
|
|
|
|
|
||
|
Reconciliation of net loss:
|
|
|
||
|
Revenues
|
|
$
|
27
|
|
|
Acquisition and transaction related
|
|
(118
|
)
|
|
|
Depreciation and amortization
|
|
(16
|
)
|
|
|
Other operating expenses
|
|
(71
|
)
|
|
|
Net loss (in accordance with GAAP)
(1)
|
|
$
|
(178
|
)
|
|
|
|
Six Months Ended
|
||
|
(In thousands)
|
|
June 30, 2013
|
||
|
Selling commissions and dealer manager fees
|
|
$
|
2,745
|
|
|
Other offering costs
|
|
2,275
|
|
|
|
Total offering costs
|
|
$
|
5,020
|
|
|
|
|
Six Months Ended
|
||
|
(In thousands)
|
|
June 30, 2013
|
||
|
Total commissions paid to the Dealer Manager
|
|
$
|
2,745
|
|
|
Less:
|
|
|
||
|
Commissions to participating brokers
|
|
(1,832
|
)
|
|
|
Reallowance to participating broker dealers
|
|
(215
|
)
|
|
|
Net to the Dealer Manager
|
|
$
|
698
|
|
|
|
AMERICAN REALTY CAPITAL HEALTHCARE TRUST II, INC.
|
|
|
|
By:
|
/s/ Thomas P. D'Arcy
|
|
|
|
Thomas P. D'Arcy
|
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|
|
By:
|
/s/ Brian S. Block
|
|
|
|
Brian S. Block
|
|
|
|
Executive Vice President, Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer) |
|
Exhibit No.
|
|
Description
|
|
10.9 *
|
|
Agreement for Purchase and Sale of Real Property by and between American Realty Capital VII, LLC and VETS Development LLC
|
|
10.10 *
|
|
Agreement for Purchase and Sale of Real Property by and between American Realty Capital V, LLC and Ouachita Medical Properties, L.C.
|
|
10.11 *
|
|
Second Amendment to Advisory Agreement, dated as of May 15, 2013, by and among American Realty Capital Healthcare Trust II, Inc., American Realty Capital Healthcare Trust II Operating Partnership, L.P. and American Realty Capital Healthcare II Advisors, LLC
|
|
10.12 *
|
|
Letter Agreement for Purchase and Sale of Real Property, dated as of May 21, 2013, by and between American Realty Capital V, LLC and Ouachita Medical Properties, L.C.
|
|
10.13 *
|
|
Letter Agreement for Purchase and Sale of Real Property, dated as of June 20, 2013, by and between American Realty Capital V, LLC and Ouachita Medical Properties, L.C.
|
|
10.14 *
|
|
Letter Agreement for Purchase and Sale of Real Property, dated as of June 24, 2013, by and between American Realty Capital V, LLC, as assigned to ARHC OCWMNLA01, LLC, and Ouachita Medical Properties, L.C.
|
|
31.1 *
|
|
Certification of the Principal Executive Officer of the Company pursuant to Securities Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2 *
|
|
Certification of the Principal Financial Officer of the Company pursuant to Securities Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32 *
|
|
Written statements of the Principal Executive Officer and Principal Financial Officer of the Company pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101 *
|
|
XBRL (eXtensible Business Reporting Language). The following materials from American Realty Capital Healthcare Trust II, Inc.'s Quarterly Report on Form 10-Q for the three months ended June 30, 2013, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations and Comprehensive Loss, (iii) the Consolidated Statement of Changes in Equity, (iv) the Consolidated Statements of Cash Flows and (v) the Notes to the Consolidated Financial Statements. As provided in Rule 406T of Regulation S-T, this information in furnished and not filed for purpose of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|